13D/A filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC and 4 other reporting persons reported 15,628,395 STXS shares, 15.3% of the class, as of 2026-11-09, in a 13D/A accepted by EDGAR 2026-11-12 22:00:14 UTC.
- Accession
- 0001104659-26-126321
- Filer
- CIK 1389933
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- STXS · Stereotaxis, Inc.
- Shares
- 15,628,395
- Percent of class
- 15.3%
- Event date
- 2026-11-09
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group DAFNA Capital Management LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| DAFNA Capital Management, LLC | IA,OO | 0 | 15,333,446 | 0 | 15,333,446 | 15,333,446 | 15.1% |
| Dr. Nathan Fischel | IN,HC | 294,949 | 15,333,446 | 294,949 | 15,333,446 | 15,628,395 | 15.3% |
| Dr. Fariba Ghodsian | IN,HC | 0 | 15,333,446 | 0 | 15,333,446 | 15,333,446 | 15.1% |
| DAFNA LifeScience, L.P. | PN | 0 | 8,005,938 | 0 | 8,005,938 | 8,005,938 | 7.9% |
| DAFNA LifeScience Select, L.P. | PN | 0 | 7,327,508 | 0 | 7,327,508 | 7,327,508 | 7.3% |